Medical devices must be designed in such a way that they do not have any adverse or undesirable effects on the user. The EN ISO 10993 series of standards describes biological assessment and testing as part of a risk management system. Cytotoxicity testing is an important test point for all medical devices that come into direct contact with the body.
In accordance with the standard, UFAG Laboratorien AG is investigating whether extracts from medical devices adversely affect mammalian cells in vitro. The cellular viability and morphology of the cells are determined microscopically and by photometric measurement of the cellular metabolic processes.
The test in accordance with EN ISO 10993-5 provides meaningful information for product development and the selection of suitable materials as well as for batch release.
We are a GMP-certified, ISO 17025 accredited Swiss contract laboratory with many years of experience in the testing of medical devices. The cytotoxicity tests carried out at UFAG Laboratorien AG are accredited by the SAS.
Read on to see which points you need to observe, or alternatively you can contact us.